Market Place
Sourcing Support
Intra-Cellular To Participate In 3 Upcoming Investor Conferences
19 Nov 2024 //
GLOBENEWSWIRE
Intra-Cellular Therapies Present at Psych Congress & NEI Congress
07 Nov 2024 //
GLOBENEWSWIRE
Intra-Cellular`s unstoppable Caplyta nails another trial
06 Nov 2024 //
FIERCE PHARMA
Intra-Cellular Therapies Reports Q3 Results, Raises Sales Guidance
30 Oct 2024 //
GLOBENEWSWIRE
Intra-Cellular To Host Q3 2024 Financial Results Webcast
17 Oct 2024 //
GLOBENEWSWIRE
Intra-Cellular Reports ECNP Congress 2024 Presentations
23 Sep 2024 //
GLOBENEWSWIRE
Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences
28 Aug 2024 //
GLOBENEWSWIRE
Intra-Cellular To Present At Canaccord Genuity Growth Conference
08 Aug 2024 //
GLOBENEWSWIRE
Intra-Cellular Reports Q2 2024 Results, Raises CAPLYTA Sales Guidance
07 Aug 2024 //
GLOBENEWSWIRE
Intra-Cellular Therapies Appoints Sanjeev Narula As CFO
07 Aug 2024 //
GLOBENEWSWIRE
Intra-Cellular Therapies To Host Q2 2024 Results Call And Webcast
24 Jul 2024 //
GLOBENEWSWIRE
Intra-Cellular closing in on major depression nod for Caplyta
19 Jun 2024 //
FIERCE PHARMA
Intra-Cellular Announces Positive Phase 3 Results For Lumateperone In Depression
18 Jun 2024 //
GLOBENEWSWIRE
Intra-Cellular To Present At Goldman Sachs Healthcare Conference
10 Jun 2024 //
GLOBENEWSWIRE
Intra-Cellular At Jefferies Healthcare Conference
29 May 2024 //
GLOBENEWSWIRE
Intra-Cellular Psychopharmacology Data: Annual Meeting Presentations Highlighted
23 May 2024 //
GLOBENEWSWIRE
Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
08 May 2024 //
GLOBENEWSWIRE
Intra-Cellular Therapies Reports First Quarter 2024 Financial Results
07 May 2024 //
GLOBENEWSWIRE
Intra-Cellular Q1 2024 Results Call And Webcast
30 Apr 2024 //
GLOBENEWSWIRE
Intra-Cellular Closes $575M Public Offering
24 Apr 2024 //
GLOBENEWSWIRE
Intra-Cellular Therapies Prices Public Offering of Common Stock
17 Apr 2024 //
GLOBENEWSWIRE
Intra-Cellular Announces Positive Phase 3 Results for Lumateperone in MDD
16 Apr 2024 //
GLOBENEWSWIRE
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
16 Apr 2024 //
GLOBENEWSWIRE
Intra-Cellular Therapies Promotes Dr. Michael Halstead to President
20 Mar 2024 //
CONTRACT PHARMA
Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes
19 Mar 2024 //
GLOBENEWSWIRE
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
06 Mar 2024 //
GLOBENEWSWIRE
Intra-Cellular to Present at the 44th Annual TD Cowen Health Care Conference
27 Feb 2024 //
GLOBENEWSWIRE
Intra-Cellular Reports Fourth Quarter And Full-Year 2023 Financial Results
22 Feb 2024 //
GLOBENEWSWIRE
Intra-Cellular to Host Fourth Quarter and Full Year 2023 Financial Results
08 Feb 2024 //
GLOBENEWSWIRE
Intra-Cellular to Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 Jan 2024 //
GLOBENEWSWIRE
Intra-Cellular Therapies Highlights Data Presentations at Annual Meeting
05 Dec 2023 //
GLOBENEWSWIRE
Intra-Cellular to Present at the 6th Annual Evercore ISI HealthCONx Conference
15 Nov 2023 //
GLOBENEWSWIRE
Intra-Cellular Therapies Reports Third Quarter 2023 Financial Results
02 Nov 2023 //
GLOBENEWSWIRE
Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
31 Oct 2023 //
GLOBENEWSWIRE
Intra-Cellular to Host Third Quarter 2023 Financial Results Conference
26 Oct 2023 //
GLOBENEWSWIRE
Intra-Cellular to Present at the 2023 Cantor Fitzgerald Global Conference
20 Sep 2023 //
GLOBENEWSWIRE
Intra-Cellular Announces Positive Results from Study 403 in Mixed Features
11 Sep 2023 //
PRESS RELEASE
Intra-Cellular Therapies Announces Presentations at Psych Congress 2023
11 Sep 2023 //
GLOBENEWSWIRE
Intra-Cellular to Present at the Morgan Stanley 21st Annual Global Conference
05 Sep 2023 //
GLOBENEWSWIRE
Intra-Cellular re-ups winning ad as bipolar drug builds momentum
08 Aug 2023 //
FIERCE PHARMA
Intra-Cellular Therapies to Present at Canaccord Genuity 43rd Annual Conference
04 Aug 2023 //
GLOBENEWSWIRE
Intra-Cellular Therapies Reports Second Quarter 2023 Financial Results
03 Aug 2023 //
GLOBENEWSWIRE
Intra-Cellular Therapies to Host Q2 2023 Financial Results Conference
28 Jul 2023 //
GLOBENEWSWIRE
Intra-Cellular shareholders have earned a 25% CAGR over the last five years
12 Jul 2023 //
SIMPLYWALL
Intra-Cellular to Present at the Goldman Sachs 44th Annual Global Conference
05 Jun 2023 //
GLOBENEWSWIRE
Intra-Cellular Therapies Announces CAPLYTA Data Presentations
31 May 2023 //
GLOBENEWSWIRE
Intra-Cellular Therapies Reports 1Q 2023 FYR and Provides Corporate Update
04 May 2023 //
GLOBENEWSWIRE
Intra-Cellular Therapies to Present at Two Upcoming Investor Conferences
02 May 2023 //
GLOBENEWSWIRE
Intra-Cellular Therapies to Host 1Q 2023 FYR Conference Call and Webcast
26 Apr 2023 //
GLOBENEWSWIRE
Morgan Stanley Initiates Coverage of ITCI with Overweight Recommendation
20 Apr 2023 //
NASDAQ
Intra-Cellular to Present at 22nd Annual Needham Virtual Healthcare Conference
11 Apr 2023 //
GLOBENEWSWIRE
Intra-Cellular Therapies gets a boost on PhIII depression drug data
29 Mar 2023 //
ENDPTS
Intra-Cellular Announces Positive Results from Study 403 Evaluating Lumateperone
28 Mar 2023 //
GLOBENEWSWIRE
Intra-Cellular Therapies Reports 4Q and Full-Year 2022 Financial Results
01 Mar 2023 //
GLOBENEWSWIRE
Intra-Cellular : A loss of 59 cents per share anticipated for Q4
27 Feb 2023 //
KALKINEMEDIA
Intra-Cellular Therapies to Host Q4 and Full Year 2022 Financial Results
14 Feb 2023 //
GLOBENEWSWIRE
Intra-Cellular Therapies to Present at SVB Securities Biopharma Conference
08 Feb 2023 //
GLOBENEWSWIRE
BlackRock Increases Position in Intra-Cellular Therapies (ITCI)
03 Feb 2023 //
NASDAQ
Intra-Cellular Therapies to Present at the 41st Annual J.P. Morgan Conference
03 Jan 2023 //
GLOBENEWSWIRE
Intra-Cellular Therapies Highlights New CAPLYTA Bipolar Depression Data
08 Dec 2022 //
GLOBENEWSWIRE
